240 related articles for article (PubMed ID: 34143617)
1. Ultrasmall Molybdenum Disulfide Quantum Dots Cage Alzheimer's Amyloid Beta to Restore Membrane Fluidity.
Li Y; Tang H; Zhu H; Kakinen A; Wang D; Andrikopoulos N; Sun Y; Nandakumar A; Kwak E; Davis TP; Leong DT; Ding F; Ke PC
ACS Appl Mater Interfaces; 2021 Jun; 13(25):29936-29948. PubMed ID: 34143617
[TBL] [Abstract][Full Text] [Related]
2. Graphene quantum dots obstruct the membrane axis of Alzheimer's amyloid beta.
Tang H; Li Y; Kakinen A; Andrikopoulos N; Sun Y; Kwak E; Davis TP; Ding F; Ke PC
Phys Chem Chem Phys; 2021 Dec; 24(1):86-97. PubMed ID: 34878460
[TBL] [Abstract][Full Text] [Related]
3. Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells.
Ng J; Kamm RD; Wohland T; Kraut RS
J Mol Biol; 2018 Sep; 430(18 Pt B):3439-3453. PubMed ID: 29746852
[TBL] [Abstract][Full Text] [Related]
4. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
5. Molybdenum Disulfide Nanoparticles as Multifunctional Inhibitors against Alzheimer's Disease.
Han Q; Cai S; Yang L; Wang X; Qi C; Yang R; Wang C
ACS Appl Mater Interfaces; 2017 Jun; 9(25):21116-21123. PubMed ID: 28613069
[TBL] [Abstract][Full Text] [Related]
6. Cysteamine functionalized MoS
Sun LJ; Qu L; Yang R; Yin L; Zeng HJ
Int J Biol Macromol; 2019 May; 128():870-876. PubMed ID: 30716371
[TBL] [Abstract][Full Text] [Related]
7. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
Rosenman DJ; Connors CR; Chen W; Wang C; García AE
J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
[TBL] [Abstract][Full Text] [Related]
8. [Cell-surface Initial Aggregation Process of Amyloid-β Peptides Studied by Fluorescence Correlation Spectroscopy].
Yano Y
Yakugaku Zasshi; 2021; 141(6):825-829. PubMed ID: 34078789
[TBL] [Abstract][Full Text] [Related]
9. Quercetin-derived red emission carbon dots: A multifunctional theranostic nano-agent against Alzheimer's β-amyloid fibrillogenesis.
Wei Z; Dong X; Sun Y
Colloids Surf B Biointerfaces; 2024 Jun; 238():113907. PubMed ID: 38608464
[TBL] [Abstract][Full Text] [Related]
10. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
11. Graphene quantum dots for the inhibition of β amyloid aggregation.
Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
[TBL] [Abstract][Full Text] [Related]
12. The interaction of beta-amyloid protein with cellular membranes stimulates its own production.
Peters I; Igbavboa U; Schütt T; Haidari S; Hartig U; Rosello X; Böttner S; Copanaki E; Deller T; Kögel D; Wood WG; Müller WE; Eckert GP
Biochim Biophys Acta; 2009 May; 1788(5):964-72. PubMed ID: 19366591
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate-derived carbonized polymer dots: A multifunctional scavenger targeting Alzheimer's β-amyloid plaques.
Lin X; Liu W; Dong X; Sun Y
Acta Biomater; 2023 Feb; 157():524-537. PubMed ID: 36503076
[TBL] [Abstract][Full Text] [Related]
14. Membrane and surface interactions of Alzheimer's Aβ peptide--insights into the mechanism of cytotoxicity.
Williams TL; Serpell LC
FEBS J; 2011 Oct; 278(20):3905-17. PubMed ID: 21722314
[TBL] [Abstract][Full Text] [Related]
15. Lipid membranes induce structural conversion from amyloid oligomers to fibrils.
Gu L; Guo Z
Biochem Biophys Res Commun; 2021 Jun; 557():122-126. PubMed ID: 33862455
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional carbon dots as a therapeutic nanoagent for modulating Cu(ii)-mediated β-amyloid aggregation.
Chung YJ; Lee BI; Park CB
Nanoscale; 2019 Mar; 11(13):6297-6306. PubMed ID: 30882825
[TBL] [Abstract][Full Text] [Related]
17. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
18. Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide.
Madhu P; Das D; Mukhopadhyay S
Phys Chem Chem Phys; 2021 Apr; 23(16):9686-9694. PubMed ID: 33908427
[TBL] [Abstract][Full Text] [Related]
19. Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
Jang H; Arce FT; Ramachandran S; Kagan BL; Lal R; Nussinov R
Chem Soc Rev; 2014 Oct; 43(19):6750-64. PubMed ID: 24566672
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels.
Tofoleanu F; Buchete NV
Prion; 2012; 6(4):339-45. PubMed ID: 22874669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
